Dionex to purchase ESA Biosciences’ HPLC portfolio
Dionex has entered into an asset purchase agreement with ESA Biosciences, a wholly owned subsidiary of Magellan Biosciences, to purchase ESA Biosciences’ HPLC-related products, HPLC clinical assays, laboratory services and assets.
This acquisition will add three HPLC detector families to the Dionex HPLC product portfolio:
- Corona Family of Universal Charged Aerosol Detectors (CAD) is the ‘universal’ HPLC detector targeting pharmaceutical and biopharmaceutical development, manufacturing and QA/QC processes.
- CoulArray and Coulochem detectors are electrochemical detectors targeting neuroscience, clinical, and metabolomics research applications.
Combined with Dionex expertise in electrochemistry detection for carbohydrates and glycobiology, this acquisition will position Dionex as the leading provider of comprehensive electrochemistry solutions for liquid chromatography.
Vaxxas appoints former Merck Global Vaccines President David Peacock as CEO
To lead the commercialisation of Vaxxas's proprietary high‑density microarray patch (HD‑MAP)...
Optics11 Life appoints Jacquelien ten Dam as CEO
Optics11 Life plans to accelerate its commercial growth in key markets while building strategic...
Epilepsy pioneer elected President of Aust Academy of Science
Laureate Professor Sam Berkovic — one of the world's most respected neurologists...
